PULMONX CORPORATION Deferred Income Tax Expense (Benefit)
PULMONX CORPORATION (LUNG) reported Deferred Income Tax Expense (Benefit) of -$19.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-10
- PULMONX CORPORATION deferred income tax expense (benefit) for fiscal 2025 was -$19.00K.
- PULMONX CORPORATION deferred income tax expense (benefit) for fiscal 2024 was -$24.00K, a 192.31% decline from fiscal 2023.
- PULMONX CORPORATION deferred income tax expense (benefit) for fiscal 2023 was $26.00K, a 52.73% decline from fiscal 2022.
- PULMONX CORPORATION deferred income tax expense (benefit) for fiscal 2022 was $55.00K.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$19.00K 10-K · filed 2026-03-10 |
| 2024-12-31 | -$24.00K 10-K · filed 2026-03-10 |
| 2023-12-31 | $26.00K 10-K · filed 2025-02-25 |
| 2022-12-31 | $55.00K 10-K · filed 2024-02-27 |
| 2021-12-31 | -$24.00K 10-K · filed 2023-03-01 |
| 2020-12-31 | $19.00K 10-K · filed 2022-03-01 |
| 2019-12-31 | -$5.00K 10-K · filed 2021-03-15 |
| 2018-12-31 | -$197.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |